Microbiome Report for Week Ending 2/2/19

Azitra, Inc., a company developing microbiome-based cosmetics and therapeutics to treat skin diseases and conditions, announced on 1/30/19 that enrollment has been completed for the first human safety study of AZT-04. AZT-04 is the Company’s lead product candidate and is in development for cosmetic use and select therapeutic indications.